05.135.2014 - Non-contact vital sign monitoring a reality with investment from ORA and IP Group

Oxehealth closes latest round of funding with £2m of investmentOxehealth, the vital signs software developer spun out from the University of Oxford's Institute of Biomedical Engineering, today announces the results of its latest round of funding, which has seen investment from IP Group plc, one of its managed funds, IP Venture Fund II LP, and ORA.The company's patented Oxecam clinical technology, developed by world-leading scientist Professor Lionel Tarassenko, enables a digital video camera, tablet or... Source: RealWire - View Press Release